Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Guys, you want to think positively go look at what happened to SIML today. It was in the sub-pennies and with news of signing a major contract it jumped today to .04 in one day. The same thing will happen with LLBO once the device is approved and we sign on a major partner. So hold those shares. This will workout.
Mark, LLBO announced the Asia launch in April 17. It was fall of 18 before anything happened. Thus, I think you need to plan on a late 2020 at the earliest for a US launch. Most likely 2021. I decided to hold hoping that LLBO/Cyrcadia might get a buyout or partnership offer following "positive" results in Asia which could happen later this year.
If you date is correct..one month from today....FDA Meeting. Can you copy and post the article?
Chaka, I agree. Especially big bio and AI companies. They will pounce on this as soon as positive data begins rolling in. I expect many "first right of refusals" partnership possibilities. Stay positive folks.
I believe there is plenty of good news to come. In order, first we will hear is that a financial partner has joined the Cyrcadia Health team to provide financing for a larger distribution of the itbra program. IMO this will happen within the next six months as the initial Asia results provide proof of concept followed by FDA approvals and launch in North America over the next year or so followed almost immediately by buy-out offers or partnerships. Adoption by the American Cancer Society and other breast cancer organizations as an approved breast cancer screening option especially for women with dense breast tissue. It will be an exciting couple of years. Hang in there guys this is just getting started.
Guys, the big bio-tech's are buying the smaller companies. Another one this morning. CNBC all over it. Once we get some positive outcomes from Asia and FDA approval...we can expect some great results from this investment.
Chaka and Lefty you’re comments are why no one is selling. The interview was outstanding and the future is bright.
The better thought is "why is no one selling????"
Thanks, Ms. Wong asked all the right questions. I've listened to her report several times and each time I hear something positive. Progress is the name of the game. Now we need FDA approval and off we go.
Guys, here is a follow-up report from Isabel Wong from the Hong Kong International Business Channel. Great progress being made in Asia, willing to accept a financial partner to expand reach, will not sell the company at this point, looking for other possible uses of the technology and lots more information...see what you learn from the report and post your thoughts here is the link: [url]: https://www.facebook.com/hkibcnews/videos/255775205362599/
[/url]
OK, let's flip this discussion around 180 degrees...
Let's say you are GE, Hologic, Xoram, or Siemens and you make mammography equipment for a living. This Cyrcadia comes along and all of a sudden your sales will be greatly impacted if this little device is approved.
Why not go ahead and buy the whole company and either add it to your inventory of shelve it. This happens quite often. Either way I only see blue skies for this investment.
If you are considering selling think about this:
"Merck to Buy Immune Design for $5.85 A Share"
You may have seen this headline today..it looks like big pharma are looking at these small plays and paying up for them.
While it's a long shot before FDA approval its not out of the question.
MMs setting up today for a sell off. Don't bite.
Chaka,another important asset that is often overlooked but extremely important to a potential buyout is the data. Cyrcadia will have the largest data base of breast cancer data in the world. Thus, companies like 23 and me, will pay for information/data sets that may enhance their business. They are already touting using their service for predictive health issues. Our data will certainly enhance their ability to more DNA kits. Data is the gold.
Lefty, we need FDA approval before this will take off. Once we achieve this both a potential buyout and share price movement (positive) becomes possible. IMO until that happens we continue to spin our wheels. It was good to read that LLBO/Cyrcadia are moving quickly in that direction. Don't you think if you were big bio and believed in the produce, you might start buying large blocks of LLBO shares now and use the appreciation upon FDA approval to buy the company. Seems like a good financial strategy to me. We'll see over the next few weeks if this gain traction.
I hope so because otherwise we will need a miracle. Glad the apostles are on board.
Wrestler, I can ask the second part of the question. My source is only associated with C/Asia. Not CH or the website. I'll find out about an public announcement for the launch in Asia. Anyone else have a question?
What news is everyone interested in hearing from Cyrcadia? I will reach out to my source and see if I can get some answers. I've already mentioned the itBra has been launched in Asia.
Sometime in 2021 is my guess.
Just got notice today..
Mammography Facility Adverse Event and Action Report – February 01, 2019: South Shore Radiology A Division of Prohealthcare Howard Beach
This is the kind of situation the itBra can help resolve...
Mammography Facility Against Which There Was An Adverse Action
The State of New York
Facility Name and Address:
South Shore Radiology
A Division of Prohealthcare- Howard Beach
156-36A Cross Bay Blvd.
Howard Beach, NY 11414
Adverse Event:
On August 13, 2018, the American College of Radiology (ACR) initiated an Additional Mammography Review (AMR) of mammograms performed by this facility due to the fact that the facility used an unaccredited digital breast tomosynthesis (DBT) mammography unit to image patients.
On September 28, 2018, the ACR notified the FDA and the facility that the AMR revealed serious deficiencies with clinical image quality and failed to meet the ACR’s clinical image evaluation criteria.
100% agree.
Cyrcadia Asia, Ltd., a corporation incorporated in Hong Kong, is a licensee of Cyrcadia, Inc. with the exclusive right to use Cyrcadia Health branding in connection with, and to commercialize, the ...
I think this settles the discussion about who owns what...
Cyrcadia owns the patents/ect. to the itBra. CA is a licensee with rights to sell the itBra in Asia.
Thus, Cyrcadia receives a licensee's fee and LLBO shares in both the fee paid to Cyrcadia Health via it's 47% ownership of CH along with a small direct investment in CA.
There you go.
When a doctor confirms he/she found/saved a life via this technology this stock will balloon higher then anyone of us can imagine.
Can’t happen. Cyrcadia Health owns a majority of CA.
Cyrcadia also owns the data base.
Seeing some follow-thru today. Am I the only one left?
Better volume today. Hope it continues.
As usual you are WRONG. The initial launch is in all Asian countries EXECPT for China over the next year. China will launch in 2020 the same time it come to the USA. Try to stay current.
Just noticed the CA website is down for maintenance. I bet when it comes up they will officially announce the launch of the itBra and where you can purchase it. BOOM!!
It launched last week via my source. Are u not reading other posts. Cyrcadia isn’t going to issue a big PR. They see themselves as a private company. Please stop making irrelevant comments? Take the night off and watch the Australian Open.
BUT, the first buyout offer will occur in 2019. It will be rejected and a second company will make a serious offer that will be accepted. IMO
I think it will 2020 before the itBra reaches the US. So you win!!
So based on everyone's input am I correct in saying that LLBO will earn little via ASIA as compared to the potential earning from the USA launch or an overall buyout. Still not sure how the data (long term earning winner) benefits LLBO but I'm sure they have a piece of that business as well. Thoughts/different perspectives/other ideas.
~47% LLBO Cyrcadia Health ownership...from Confirm
Thanks, but we also own 47% of Cyrcadia USA and Cyrcadia USA owns 43% of Cyrcadia Asia therefore LLBO should benefit indirectly from its ownership of Cyrcadia USA along with our direct and rather small position in Cyrcadia Asia. Does this sound correct?
Thanks, do you happen to know how much of Cyrcadia Asia does Cyrcadia USA own?
How much of Cyrcadia USA does LLBO own? Great news out of Asia on the distribution agreement. CA is moving fast.
Great article on AI hub being Asia for devices. We could use some additional insight. I think this third party news is important but not as meaningful as something/update from CA. The stars are lining up just right...
I will as soon as Cyrcadia releases an update otherwise I don't think it will be approved. Lots of good news in the press but nothing from the Co. so once we hear an update I'll contact the administrator and ask permission to list it on the site.